99% CAS61489-71-2 Pharmaceutical Steroid Hormone 75iu HMG

99% CAS61489-71-2 Pharmaceutical Steroid Hormone 75iu HMG

CAS No:9002-68-0
Specifications:75iu/vial

Product Details

We goal to see good quality disfigurement within the manufacturing and provide the most effective support to domestic and overseas shoppers wholeheartedly for HGH Purple Top, SOMATROPIN OEM, Recombinant Human Growth Hormone 10iu. With a wide range, good quality, reasonable prices and stylish designs, our products are extensively used in beauty and other industries. All employees of our company will provide you with better and more complete products with a high degree of professionalism, strict quality control concepts, scientific management methods, and timely and thoughtful services. Relying on professional R&D technology, diversified and high-quality products and fast and thoughtful service system, our company continues to meet and exceed the growing needs of customers.

CAS No:9002-68-0

Specifications:75iu/vial

Purity:

price:If you need HMG 75iu Injection price list, please contact customer service. 

Storage conditions: Store at 2 - 7°C. Keep tightly closed. Store in a cool dry place.

Molecular weight:

Molecular formula:


Product description:

HMG injection 75iu/vial Pharmaceutical raw materials High purity HMG Most popular products Menotropin (also called human menopausal gonadotropin or hMG) is a hormonally active medication for the treatment of fertility disturbances. Frequently the plural is used as the medication is a mixture of gonadotropins. Menotropins are extracted from the urine of postmenopausal women. Urine of postmenopausal women reflects the hypergonadotropic state of menopause -levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) are high - and contain a mixture of these gonadotropins. Other protein substances may be present, including small amounts of human chorionic gonadotropin (hCG). 


In 1949 Piero Donini found a relatively simple method to extract gonadotropins from urine of postmenopausal women. Menotropins were successfully introduced into clinical use by Bruno Lunenfeld in 1961. While earlier menotropin medications contained FSH and LH at a 1:1 ratio, the recognition that it is FSH that is critical for follicle stimulation has led to development of newer preparations that contain a much higher FSH/LH ratio, Fertinex being an example. Menotropin preparations are designed for use in selected women where they stimulate the ovaries to mature follicles, thus making them more fertile. They are administered by typically daily injection, intramuscularly or subcutaneously, for about ten days under close supervision to adjust dose and duration of therapy. They can also be used in hypogonadal men to stimulate sperm production. Human urinary-derived menotropin preparations are exposed to the theoretical risk of infection from menopausal donors of urine. Nevertheless, the failure to irrefutably demonstrate infectivity following intracerebral inoculation with urine from transmissible spongiform encephalopathy(TSE)-infected hosts suggests that the risk associated with products derived from urine is merely theoretical. Recombinant gonadotropins have to a large degree replaced hMG in fertility treatments. The recombinant process allows for the production of pure FSH or LH not "contaminated" by other proteins that may be present after urinary extraction. While some head-on studies seem not to suggest that "pure FSH" gives better results than hMG., others claim that recombinant FSH is more efficient and reduces costs. A Cochrane Collaboration analysis did not reveal major differences in clinical outcomes when comparing urinary versus recombinant FSH. The Practice Committee of the American Society for Reproductive Medicine reported: "Compared with earlier crude animal extracts, modern highly purified urinary and recombinant gonadotropin products have clearly superior quality, specific activity, and performance. There are no confirmed differences in safety, purity, or clinical efficacy among the various available urinary or recombinant gonadotropin products."


'Positiveness, wise change, joint efforts, and win-win' is our corporate culture. We have been actively promoting the development of 99% CAS61489-71-2 Pharmaceutical Steroid Hormone 75iu HMG. Looking forward to your inquiry. In the future development process, we will continue to strengthen our scientific research strength and take the road of professional, high-quality and large-scale development.
Hot Tags: HMG 75iu injection, manufacturers, suppliers, factory, customized, buy, wholesale, price, HCG OEM, Growth Hormone Releasing Peptide-6 2mg, Injectable Hgh 10iu, CJC-1295 2mg Injection, Polypeptide Synthesis Drugs, Growth Hormone Releasing Peptide-2 5mg

Inquiry

You Might Also Like